AQP4 and myeloid sarcoma: This finding is consistent with the evidence from pathology of direct damage to axons in NMOSD, mediated by anti-AQP4 antibody astrocytopathy22,26, while in MS functional transmission impairment and axonal degeneration occurs mainly as a secondary effect of demyelination27.